Paula de Lima Vieira-Brock
Research Subjects
Paula de Lima Vieira-Brock has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Brent Vaughan
Cognito Therapeutics, Cambridge, MA USA
3 shared publications - David Vollmer
Scientific Research Division, 4Life Research, Sandy, UT 84070, USA
2 shared publications Glen R. Hanson
Department of Pharmacology and Toxicology University of Utah, Salt Lake City, UT 84112, United States
2 shared publications- Lisa M. McFadden
Biomedical and Translational Science, University of South Dakota, United States
2 shared publications Scott C. Allen
Department of Pharmacology and Toxicology University of Utah, Salt Lake City, UT 84112, United States
2 shared publications- Shannon M. Nielsen
University of Utah School of Medicine, Salt Lake City, Utah
2 shared publications
Latest Publications
- Open Access
- 29 October 2021
- Published by Elsevier in Journal of Immunological Methods
- Vol. 499, 113175
Method development for the analysis of PBMC-mediated killing of K562 cells by bovine colostrum
- 29 October 2021
- Published by Elsevier in Journal of Immunological Methods
- Vol. 499, 113175
Open AccessMethod development for the analysis of PBMC-mediated killing of K562 cells by bovine colostrum
- Open Access
- 1 January 2018
- Vol. 10 (1) , 37-43
Thermogenic Blend Alone or in Combination with Whey Protein Supplement Stimulates Fat Metabolism and Improves Body Composition in Mice
Background: Certain food ingredients promote thermogenesis and fat loss. Similarly, whey protein improves body composition. Due to this potential synergistic effect, a blend of thermogenic food ingredients containing African mango, citrus fruit extract, Coleus forskohlii, dihydrocapsiate, and red pepper was tested alone and in combination with a whey protein supplement for its effects on body composition in sedentary mice during high-fat diet. Objective: The objective of this study was to evaluate the interaction of thermogenic foods on improving body composition during consumption of an unhealthy diet. Materials and Methods: C57BL/6J young adult male mice (n = 12) were placed on a 60% high-fat diet for 4 weeks and subsequently randomly assigned to receive daily dosing by oral gavage of vehicle, the novel blend alone or with whey protein supplement for another 4 weeks. Body composition, thermal imaging of brown adipose tissue (BAT), mitochondrial BAT uncoupling protein 1 (UCP1), and plasma levels of leptin were assessed. Results: Novel blend alone and in combination with protein supplement attenuated body weight gain, fat, and increased surface BAT temperature in comparison to vehicle control and to baseline (P < 0.5). The combination of novel blend and whey protein supplement also significantly increased UCP1 protein expression in BAT mitochondria in comparison to vehicle control and novel blend alone (P < 0.5). Conclusions: These data indicate that this novel blend stimulates thermogenesis and attenuates the gain in body weight and fat in response to high-fat diet in mice and these effects were improved when administered in combination with whey protein supplement.
- 1 January 2018
- Vol. 10 (1) , 37-43
Open AccessThermogenic Blend Alone or in Combination with Whey Protein Supplement Stimulates Fat Metabolism and Improves Body Composition in Mice
Background: Certain food ingredients promote thermogenesis and fat loss. Similarly, whey protein improves body composition. Due to this potential synergistic effect, a blend of thermogenic food ingredients containing African mango, citrus fruit extract, Coleus forskohlii, dihydrocapsiate, and red pepper was tested alone and in combination with a whey protein supplement for its effects on body composition in sedentary mice during high-fat diet. Objective: The objective of this study was to evaluate the interaction of thermogenic foods on improving body composition during consumption of an unhealthy diet. Materials and Methods: C57BL/6J young adult male mice (n = 12) were placed on a 60% high-fat diet for 4 weeks and subsequently randomly assigned to receive daily dosing by oral gavage of vehicle, the novel blend alone or with whey protein supplement for another 4 weeks. Body composition, thermal imaging of brown adipose tissue (BAT), mitochondrial BAT uncoupling protein 1 (UCP1), and plasma levels of leptin were assessed. Results: Novel blend alone and in combination with protein supplement attenuated body weight gain, fat, and increased surface BAT temperature in comparison to vehicle control and to baseline (P < 0.5). The combination of novel blend and whey protein supplement also significantly increased UCP1 protein expression in BAT mitochondria in comparison to vehicle control and novel blend alone (P < 0.5). Conclusions: These data indicate that this novel blend stimulates thermogenesis and attenuates the gain in body weight and fat in response to high-fat diet in mice and these effects were improved when administered in combination with whey protein supplement.
- Open Access
- 1 December 2017
- Published by Elsevier in Biochimie Open
- Vol. 5, 8-13
Comparison of antimicrobial activities of natural essential oils and synthetic fragrances against selected environmental pathogens
- 1 December 2017
- Published by Elsevier in Biochimie Open
- Vol. 5, 8-13
Open AccessComparison of antimicrobial activities of natural essential oils and synthetic fragrances against selected environmental pathogens
- Open Access
- 28 May 2012
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 126 (1-2) , 87-94
Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations
- 28 May 2012
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 126 (1-2) , 87-94
Open AccessPrior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations
- Open Access
Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high‐dose methamphetamine administration
Administration of high doses of methamphetamine (METH) causes persistent dopaminergic deficits in both nonhuman preclinical models and METH‐dependent persons. Noteworthy, adolescent [i.e., postnatal day (PND) 40] rats are less susceptible to this damage than young adult (PND90) rats. In addition, biweekly treatment with METH, beginning at PND40 and continuing throughout development, prevents the persistent dopaminergic deficits caused by a “challenge” high‐dose METH regimen when administered at PND90. Mechanisms underlying this “resistance” were thus investigated. Results revealed that biweekly METH treatment throughout development attenuated both the acute and persistent deficits in VMAT2 function, as well as the acute hyperthermia, caused by a challenge METH treatment. Pharmacokinetic alterations did not appear to contribute to the protection afforded by the biweekly treatment. Maintenance of METH‐induced hyperthermia abolished the protection against both the acute and persistent VMAT2‐associated deficits suggesting that alterations in thermoregulation were caused by exposure of rats to METH duringdevelopment. These findings suggest METH during development prevents METH‐induced hyperthermia and the consequent METH‐related neurotoxicity. Synapse 2011.
Open AccessMethamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high‐dose methamphetamine administration
Administration of high doses of methamphetamine (METH) causes persistent dopaminergic deficits in both nonhuman preclinical models and METH‐dependent persons. Noteworthy, adolescent [i.e., postnatal day (PND) 40] rats are less susceptible to this damage than young adult (PND90) rats. In addition, biweekly treatment with METH, beginning at PND40 and continuing throughout development, prevents the persistent dopaminergic deficits caused by a “challenge” high‐dose METH regimen when administered at PND90. Mechanisms underlying this “resistance” were thus investigated. Results revealed that biweekly METH treatment throughout development attenuated both the acute and persistent deficits in VMAT2 function, as well as the acute hyperthermia, caused by a challenge METH treatment. Pharmacokinetic alterations did not appear to contribute to the protection afforded by the biweekly treatment. Maintenance of METH‐induced hyperthermia abolished the protection against both the acute and persistent VMAT2‐associated deficits suggesting that alterations in thermoregulation were caused by exposure of rats to METH duringdevelopment. These findings suggest METH during development prevents METH‐induced hyperthermia and the consequent METH‐related neurotoxicity. Synapse 2011.